{"id":391194,"date":"2015-12-18T00:00:00","date_gmt":"2015-12-18T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/biolatr009-2015-biopharma-biosimilars-emerging-biosimilars-oncology-zarxio-wave-1-us\/"},"modified":"2026-04-14T10:28:24","modified_gmt":"2026-04-14T10:28:24","slug":"biolatr009-2015-biopharma-biosimilars-emerging-biosimilars-oncology-zarxio-wave-1-us","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/biolatr009-2015-biopharma-biosimilars-emerging-biosimilars-oncology-zarxio-wave-1-us\/","title":{"rendered":"Biosimilars | Emerging Biosimilars | Oncology | Zarxio Wave 1 | US"},"content":{"rendered":"<p>Abstract<\/p>\n","protected":false},"template":"","class_list":["post-391194","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-oncology","biopharma-product-biosimilars","biopharma-geography-us","biopharma-date-717"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391194\/revisions"}],"predecessor-version":[{"id":394317,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391194\/revisions\/394317"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=391194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}